2025年血液篩檢全球市場報告

預計未來幾年血液篩檢市場規模將快速成長，到2029年將達到53.3億美元，複合年成長率為11.5%。預測期內的成長歸因於醫療基礎建設、公共衛生意識提升計畫、感染疾病診斷技術的進步、全球衛生挑戰以及流行病防範措施。預測期內的主要趨勢包括感染疾病上升、自動化和效率提升、輸血需求成長、對輸血安全的重視以及病原體檢測研究。

未來五年11.5%的成長預測比我們先前的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將透過增加來自韓國和英國的核酸檢測平台和感染疾病檢測的成本、延遲捐贈者篩檢以及提高血庫的檢測成本來阻礙美國的血液安全。互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響也可能更加廣泛。

預計未來幾年，感染疾病的盛行率將推動血液篩檢市場的成長。血液檢測是常規檢測，用於檢測針對傳染源產生的特異性抗體，幫助醫護人員治療這些疾病並預防患者進一步感染。例如，美國政府機構國家生物技術資訊中心於2022年6月報告稱，過去20年，門診感染疾病的發病率成長了近三倍，從每千人8例增至26例。因此，感染疾病率的上升正在刺激血液篩檢市場的擴張。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球血液篩檢：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球血液篩檢市場：成長率分析
• 全球血液篩檢市場表現：規模與成長，2019-2024
• 全球血液篩檢市場預測：規模與成長，2024-2029年，2034年
• 全球血液篩檢：總目標市場（TAM）

第6章 市場細分

• 全球血液篩檢市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 試劑和套件
• 裝置
• 軟體和服務
• 全球血液篩檢市場：依技術、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 核酸檢測
• 酵素免疫分析法（ELISA）
• 快速檢測
• 西方墨點法
• 次世代定序（NGS）
• 全球血液篩檢市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 血庫
• 診斷中心和病理實驗室
• 醫院
• 診所
• 門診手術中心（ASC）
• 全球血液篩檢市場：按試劑和套件（按類型）細分，實際和預測，2019-2024 年、2024-2029 年、2034 年
• 診斷劑
• 檢測套組
• 全球血液篩檢市場：依設備類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 自動分析儀
• 手動測試設備
• 全球血液篩檢市場：按軟體和服務細分（按類型）、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 實驗室資訊管理系統（LIMS）
• 數據分析軟體
• 支援和諮詢服務

第7章 區域和國家分析

• 全球血液篩檢市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球血液篩檢市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 血液篩檢市場：競爭格局
• 血液篩檢市場：公司簡介
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Grifols SA Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Ortho Clinical Diagnostics Inc.
• Beckman Coulter Inc.
• Siemens Healthineers AG
• GE Healthcare
• DiaSorin SpA
• Merck KGaA
• PerkinElmer Inc.
• Bio-Techne Corporation
• Roche Diagnostics GmbH
• Danaher Corporation
• Sysmex Corporation
• Natera Inc.
• GenMark Diagnostics Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029年血液篩檢市場：提供新機會的國家
• 2029年血液篩檢市場：細分領域帶來新機會
• 2029年血液篩檢市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Blood screening involves the examination of blood, plasma, or blood components intended for transfusion or incorporation into blood-based products. This process aims to detect antibodies, tumor markers, disease-causing agents, or indicators of illnesses, and to assess the effectiveness of treatments.

The primary products used in blood screening include reagents and kits, instruments, software, and associated services. Reagents are compounds or substances enabling reactions crucial for detecting, measuring, or preparing components due to their biological or chemical activity. Kits, on the other hand, are test kits used in laboratory settings or in the field to identify specific compounds in a sample. Technologies utilized in blood screening encompass nucleic acid testing, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). These screening methods find application in various healthcare settings such as blood banks, diagnostic centers, pathology labs, hospitals, clinics, and ambulatory surgical centers (ASCs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The blood screening market research report is one of a series of new reports from The Business Research Company that provides blood screening market statistics, including blood screening industry global market size, regional shares, competitors with a blood screening market share, detailed blood screening market segments, market trends and opportunities, and any further data you may need to thrive in the blood screening industry. This blood screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood screening market size has grown strongly in recent years. It will grow from $3.15 billion in 2024 to $3.44 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increased blood transfusion requirements, rising prevalence of transmissible diseases, government regulations and standards, increasing blood donations and collection, global health concerns and pandemics.

The blood screening market size is expected to see rapid growth in the next few years. It will grow to $5.33 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to healthcare infrastructure development, public health awareness programs, advancements in infectious disease diagnostics, global health concerns and pandemic preparedness. Major trends in the forecast period include rise in infectious diseases, automation and efficiency, rising blood transfusion demands, focus on transfusion safety, research in pathogen detection.

The forecast of 11.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. blood safety by increasing the cost of nucleic acid testing platforms and infectious disease assays sourced from South Korea and the UK, thereby slowing donor screening and elevating blood bank testing expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of infectious diseases is anticipated to drive the growth of the blood screening market in the future. Blood tests are routinely conducted to detect specific antibodies produced in response to infectious agents, assisting healthcare professionals in treating these diseases and preventing further transmission among patients. For example, in June 2022, the National Center for Biotechnology Information, a U.S.-based government agency, reported that the prevalence of infectious diseases in outpatient care has nearly tripled over the past two decades, increasing from 8 to 26 per 1,000. Therefore, the growing incidence of infectious diseases is fueling the expansion of the blood screening market.

In the blood screening market, the increasing prevalence of chronic diseases is a significant driver of growth. Chronic diseases, manageable but not curable long-term conditions, necessitate precise blood compatibility matching for transfusions during medical treatments. The importance of blood transfusions is evident in managing various chronic conditions, including autoimmune diseases, hematological disorders, and cancers. Notably, projections from January 2023 by the National Library of Medicine indicate a substantial increase in the number of individuals aged 50 and older with at least one chronic condition, expected to reach 142.66 million by 2050. The rising prevalence of chronic diseases and the demand for compatible blood screening contribute significantly to the expanding blood screening market.

Leading companies in the blood screening market are advancing technologies such as liquid biopsy to improve early cancer detection, enhance treatment monitoring, and support personalized medicine strategies. A liquid biopsy is a minimally invasive procedure that examines blood or other bodily fluids to identify cancer cells or genetic material from tumors. For example, in November 2023, Guardant Health, Inc., a biotechnology firm based in the U.S., introduced its Shield blood-based screening tests. This test analyzes cell-free DNA (cfDNA) in the bloodstream, helping to identify the presence of colorectal tumors or precancerous lesions by detecting specific alterations in DNA fragments released into the blood by cancer cells.

Leading companies in the blood screening market are innovating technologies such as Vacutainers to improve the efficiency, accuracy, and safety of blood collection and testing procedures. A Vacutainer is a vacuum-sealed tube designed for collecting and preserving blood samples for laboratory analysis. For example, in April 2024, Becton Dickinson, a U.S.-based medical device manufacturer, introduced the UltraTouch feature. This advancement enables the use of a thinner needle, which is essential for reducing pain during insertion. The thinner needle aims to enhance patient comfort during blood collection procedures.

In October 2022, Pfizer Inc., a U.S.-based pharmaceutical and biotechnology company, acquired Global Blood Therapeutics, Inc. for an undisclosed sum. This acquisition is intended to enhance Pfizer's portfolio, expand its research and development capabilities, and strengthen its position in the market. Global Blood Therapeutics, Inc. is a U.S.-based biotechnology firm that focuses on providing innovative therapies for sickle cell disease and other rare blood disorders.

Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMerieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the blood screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood screening market consists of revenues earned by entities by providing transcription mediated amplification (TMA) and real-time PCR. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood screening market also includes sales of analyzer, photo colorimeter, flame photometer, hemoglobin meter, blood roller mixer, dry bath incubators, and differential blood counter. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Reagents And Kits; Instruments; Software And Services
• 2) By Technology: Nucleic Acid Testing; Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Tests; Western Blot Assays; Next-Generation Sequencing (NGS)
• 3) By End User: Blood Banks; Diagnostic Centers And Pathology Labs; Hospitals; Clinics; Ambulatory Surgical Centers (ASCs)
• Subsegments:
• 1) By Reagents And Kits: Diagnostic Reagents; Testing Kits
• 2) By Instruments: Automated Analyzers; Manual Testing Equipment
• 3) By Software And Services: Laboratory Information Management Systems (LIMS); Data Analysis Software; Support And Consulting Services
• Companies Mentioned: Abbott Laboratories; Grifols S.A.; Becton Dickinson and Company; F. Hoffmann-La Roche AG; bioMerieux S.A.; Bio-Rad Laboratories Inc.; Thermo Fisher Scientific Inc.; Ortho Clinical Diagnostics Inc.; Beckman Coulter Inc.; Siemens Healthineers AG; GE Healthcare; DiaSorin S.p.A.; Merck KGaA; PerkinElmer Inc.; Bio-Techne Corporation; Roche Diagnostics GmbH; Danaher Corporation; Sysmex Corporation; Natera Inc.; GenMark Diagnostics Inc.; QIAGEN N.V.; Hologic Inc.; Luminex Corporation; Trinity Biotech plc; Fujirebio Inc.; OraSure Technologies Inc.; Immunetics Inc.; Accelerate Diagnostics Inc.; Cepheid Inc.; T2 Biosystems Inc.; Haemonetics Corporation; HTG Molecular Diagnostics Inc.; Verax Biomedical Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Screening Market Characteristics

3. Blood Screening Market Trends And Strategies

4. Blood Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Blood Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global Blood Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Blood Screening Market Growth Rate Analysis
• 5.4. Global Blood Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Blood Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Blood Screening Total Addressable Market (TAM)

6. Blood Screening Market Segmentation

• 6.1. Global Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents and Kits
• Instruments
• Software and Services
• 6.2. Global Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nucleic Acid Testing
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Tests
• Western Blot Assays
• Next-Generation Sequencing (NGS)
• 6.3. Global Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Banks
• Diagnostic Centers and Pathology Labs
• Hospitals
• Clinics
• Ambulatory Surgical Centers (ASCs)
• 6.4. Global Blood Screening Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Reagents
• Testing Kits
• 6.5. Global Blood Screening Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Analyzers
• Manual Testing Equipment
• 6.6. Global Blood Screening Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Information Management Systems (LIMS)
• Data Analysis Software
• Support And Consulting Services

7. Blood Screening Market Regional And Country Analysis

• 7.1. Global Blood Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Blood Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Screening Market

• 8.1. Asia-Pacific Blood Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Screening Market

• 9.1. China Blood Screening Market Overview
• 9.2. China Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Screening Market

• 10.1. India Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Screening Market

• 11.1. Japan Blood Screening Market Overview
• 11.2. Japan Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Screening Market

• 12.1. Australia Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Screening Market

• 13.1. Indonesia Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Screening Market

• 14.1. South Korea Blood Screening Market Overview
• 14.2. South Korea Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Screening Market

• 15.1. Western Europe Blood Screening Market Overview
• 15.2. Western Europe Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Screening Market

• 16.1. UK Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Screening Market

• 17.1. Germany Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Screening Market

• 18.1. France Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Screening Market

• 19.1. Italy Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Screening Market

• 20.1. Spain Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Screening Market

• 21.1. Eastern Europe Blood Screening Market Overview
• 21.2. Eastern Europe Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Screening Market

• 22.1. Russia Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Screening Market

• 23.1. North America Blood Screening Market Overview
• 23.2. North America Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Screening Market

• 24.1. USA Blood Screening Market Overview
• 24.2. USA Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Screening Market

• 25.1. Canada Blood Screening Market Overview
• 25.2. Canada Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Screening Market

• 26.1. South America Blood Screening Market Overview
• 26.2. South America Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Screening Market

• 27.1. Brazil Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Screening Market

• 28.1. Middle East Blood Screening Market Overview
• 28.2. Middle East Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Screening Market

• 29.1. Africa Blood Screening Market Overview
• 29.2. Africa Blood Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Blood Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Screening Market Competitive Landscape And Company Profiles

• 30.1. Blood Screening Market Competitive Landscape
• 30.2. Blood Screening Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. bioMerieux S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Blood Screening Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. Thermo Fisher Scientific Inc.
• 31.3. Ortho Clinical Diagnostics Inc.
• 31.4. Beckman Coulter Inc.
• 31.5. Siemens Healthineers AG
• 31.6. GE Healthcare
• 31.7. DiaSorin S.p.A.
• 31.8. Merck KGaA
• 31.9. PerkinElmer Inc.
• 31.10. Bio-Techne Corporation
• 31.11. Roche Diagnostics GmbH
• 31.12. Danaher Corporation
• 31.13. Sysmex Corporation
• 31.14. Natera Inc.
• 31.15. GenMark Diagnostics Inc.

32. Global Blood Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Screening Market

34. Recent Developments In The Blood Screening Market

35. Blood Screening Market High Potential Countries, Segments and Strategies

• 35.1 Blood Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Blood Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Blood Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer